Ketogenic diet administration to mice after a high-fat-diet regimen promotes weight loss, glycemic normalization and induces adaptations of ketogenic pathways in liver and kidney.
3-Hydroxybutyric Acid
/ metabolism
Animals
Blood Glucose
/ metabolism
Diet, High-Fat
/ adverse effects
Diet, Ketogenic
Dietary Carbohydrates
/ metabolism
Glucose Transporter Type 1
/ metabolism
Ketone Bodies
/ metabolism
Kidney
/ metabolism
Liver
/ metabolism
Mice
Osteoarthritis
/ metabolism
Weight Loss
HMGCS2
Histone PTMs
Ketogenesis
Ketogenic diet
β-hydroxybutyrate
Journal
Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
28
04
2022
revised:
11
08
2022
accepted:
17
08
2022
pubmed:
23
8
2022
medline:
12
10
2022
entrez:
22
8
2022
Statut:
ppublish
Résumé
The ketogenic diet (KD), characterized by very limited dietary carbohydrate intake and used as nutritional treatment for GLUT1-deficiency syndromes and pharmacologically refractory epilepsy, may promote weight loss and improve metabolic fitness, potentially alleviating the symptoms of osteoarthritis. Here, we have studied the effects of administration of a ketogenic diet in mice previously rendered obese by feeding a high fat diet (HFD) and submitted to surgical destabilization of the medial meniscus to mimic osteoarthritis. 6-weeks old mice were fed an HFD for 10 weeks and then switched to a chow diet (CD), KD or maintained on a HFD for 8 weeks. Glycemia, β-hydroxybutyrate (BHB), body weight and fat mass were compared among groups. In liver and kidney, protein expression and histone post-translational modifications were assessed by Western blot, and gene expression by quantitative Real-Time PCR. After a 10 weeks HDF feeding, administration for 8 weeks of a KD or CD induced a comparable weight loss and decrease in fat mass, with better glycemic normalization in the KD group. Histone β-hydroxybutyrylation, but not histone acetylation, was increased in the liver and kidney of mice fed the KD and the rate-limiting ketogenic enzyme HMGCS2 was upregulated - at the gene and protein level - in liver and, to an even greater extent, in kidney. KD-induced HMGCS2 overexpression may be dependent on FGF21, whose gene expression was increased by KD in liver. Over a period of 8 weeks, KD is more effective than a chow diet to induce metabolic normalization. Besides acting as a fuel molecule, BHB may exert its metabolic effects through modulation of the epigenome - via histone β-hydroxybutyrylation - and extensive transcriptional modulation in liver and kidney.
Identifiants
pubmed: 35995402
pii: S2212-8778(22)00147-8
doi: 10.1016/j.molmet.2022.101578
pmc: PMC9460189
pii:
doi:
Substances chimiques
Blood Glucose
0
Dietary Carbohydrates
0
Glucose Transporter Type 1
0
Ketone Bodies
0
3-Hydroxybutyric Acid
TZP1275679
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101578Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier GmbH.. All rights reserved.